Tech Company Financing Transactions

Ankasa Regenerative Therapeutics Funding Round

Ankasa Regenerative Therapeutics closed a Series A funding round on 12/19/2014. Investors included Avalon Ventures.

Transaction Overview

Announced On
12/19/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors

Avalon Ventures (Lead Investor) (Kevin Kinsella)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
La Jolla, CA 92037
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Pharmaceutical preparations including reactivated stem cells for organ and tissue re-growth, tissue repair, and healing.
Profile
Ankasa Regenerative Therapeutics LinkedIn Company Profile
Social Media
Ankasa Regenerative Therapeutics Company Twitter Account
Company News
Ankasa Regenerative Therapeutics News
Facebook
Ankasa Regenerative Therapeutics on Facebook
YouTube
Ankasa Regenerative Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sanford Madigan
  Sanford Madigan LinkedIn Profile  Sanford Madigan Twitter Account  Sanford Madigan News  Sanford Madigan on Facebook
Co-Founder
Scott Burkette
  Scott Burkette LinkedIn Profile  Scott Burkette Twitter Account  Scott Burkette News  Scott Burkette on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/19/2014: Ella Health venture capital transaction
Next: 12/19/2014: GameAnalytics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary